More people get cancer, yet fewer die
World Health Matters – Australia – by Gary Finnegan – Over the past quarter century in Australia, cancer incidence rates have increased while deaths from cancer have steadily… read more.
World Health Matters – Australia – by Gary Finnegan – Over the past quarter century in Australia, cancer incidence rates have increased while deaths from cancer have steadily… read more.
EMA Highlights by Gary Finnegan – The EMA has launched a public consultation on its revised guidelines covering how potential cancer drugs are assessed. The document provides guidance… read more.
by Dr. Riyaz Shah, Consultant Medical Oncologist, Kent Oncology Centre – The ASCO 2011 Annual Meeting took place in early June at the vast McCormick Place Convention Centre… read more.
Up to one-third of cancer patients experience moderate to severe pain.
by Dr Sunil Upadhyay – The incidence of small cell lung cancer accounts for nearly 15% of all diagnosed lung cancers. The majority present with locally advanced disease… read more.
by Dr Sunil Upadhyay – In 1838 E. S. Hare published work about tumours involving certain nerves.1 However, Henry Pancoast, a radiologist from Philadelphia described the classical clinical… read more.
by Dr Sunil Upadhyay – Malignant Pleural Mesothelioma (MPM) is of insidious onset and almost uniformly a fatal disease. Around 90% of the patients can be linked to… read more.
by Dr Sunil Upadhyay – Increased Met signalling in tumours can occur from increased levels of Hepatocyte Growth Factor (HGF), activating mutations within Met, and/or receptor over expression… read more.
by Dr Sunil Upadhyay – Advanced non-small cell carcinoma of the lung represents one of the major unmet needs for an effective and prolonged survival outcome. The majority… read more.
by Dr Sunil Upadhyay – Since the publication of the iPASS trial data, gefitinib has become the treatment of choice in EGFR mutation positive tumours. However, almost all… read more.
by Dr Sunil Upadhyay – At the recently held 14th World Conference on Lung Cancer in Amsterdam, on behalf of the investigators, the randomised phase III clinical trial… read more.
by Dr Sunil Upadhyay – A platinum doublet remains the current gold standard in the management of EGFR mutation negative, advanced non-small cell lung cancers. Pemetrexed is the… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.